UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 1, 2017
Accession Number:
Submission Type:
CIK: 0001651407
Company Name: Checkpoint Therapeutics, Inc.
File Number: 333-221493